Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.0250
0.00 (0.00%)
At close: Oct 15, 2026
Sofgen Pharma Market Cap
Sofgen Pharma has a market cap or net worth of $59.82 million as of October 16, 2026. It is the 28,978th most valuable company in the world and the 4,503rd biggest in the United States. Its market cap has decreased by 98.15% in one year.
Market Cap
59.82M
Enterprise Value
335.33M
Revenue
373.80M
Global Rank
Country Rank
#4,503 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 9, 2019, Sofgen Pharma's market cap has decreased from 239.85M to 59.82M, a decrease of -75.06%. That is a compound annual growth rate of -18.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 59.82M | 3.44% |
| Dec 31, 2025 | 57.83M | -78.10% |
| Dec 31, 2024 | 264.01M | -42.51% |
| Dec 29, 2023 | 459.19M | -22.48% |
| Dec 30, 2022 | 592.33M | -46.15% |
| Dec 31, 2021 | 1.10B | 323.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 269.28M |
| Cyphaira | 39.17M |
| High Sierra Technologies | 28.98M |
| Raphael Pharmaceutical | 28.25M |
| Radnostix | 26.46M |
| Earth Science Tech | 25.88M |
| MariMed | 22.97M |
| Bio Essence | 17.76M |